Across TCGA pan-cancer cohorts, RNU6-1054P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RNU6-1054P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RNU6-1054P RNA is repressed in tumor relative to normal tissue. In most cancer types RNU6-1054P is over-expressed in tumor, although a few such as KIRC and KICH show the opposite, repressed pattern.

KIRC, BRCA, and HNSC are the cancer types where RNU6-1054P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6-1054P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	II,III,IV	−0.194	.003	6	view →
BRCA	Female	All	+0.154	.012	4	view →
HNSC	All	IV	+0.205	.034	3	view →
KICH	Female	All	−0.390	.028	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: RNU6-1054P RNA expression & survival · all RNU6-1054P data types